Oxaliplatin Patent Expiration
Oxaliplatin is used for treating symptoms of depression, anxiety disorders, panic disorders, and certain types of pain. It was first introduced by Sanofi Aventis Us Llc
Oxaliplatin Patents
Given below is the list of patents protecting Oxaliplatin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Eloxatin |
US5420319 (Pediatric) | Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same |
Feb 09, 2017
(Expired) | Sanofi Aventis Us |
| Eloxatin | US5420319 | Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same |
Aug 09, 2016
(Expired) | Sanofi Aventis Us |
| Eloxatin |
US5716988 (Pediatric) | Pharmaceutically stable preparation of oxaliplatinum |
Feb 07, 2016
(Expired) | Sanofi Aventis Us |
| Eloxatin | US5716988 | Pharmaceutically stable preparation of oxaliplatinum |
Aug 07, 2015
(Expired) | Sanofi Aventis Us |
| Eloxatin |
US5338874 (Pediatric) | Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity |
Oct 07, 2013
(Expired) | Sanofi Aventis Us |
| Eloxatin |
US5290961 (Pediatric) | Platinum compound and process of preparing same |
Jul 12, 2013
(Expired) | Sanofi Aventis Us |
| Eloxatin | US5338874 | Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity |
Apr 07, 2013
(Expired) | Sanofi Aventis Us |
| Eloxatin | US5290961 | Platinum compound and process of preparing same |
Jan 12, 2013
(Expired) | Sanofi Aventis Us |
Oxaliplatin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List